Welcome to LookChem.com Sign In|Join Free
  • or
(5alpha,6alpha)-17-(2-phenylethyl)-4,5-epoxymorphinan-3,6,14-triol is a chemical compound that belongs to the morphinan class of opioids. Morphines are renowned for their potent analgesic properties, and this specific compound is likely to exhibit similar characteristics. Although the exact properties of (5alpha,6alpha)-17-(2-phenylethyl)-4,5-epoxymorphinan-3,6,14-triol are not extensively documented, it is anticipated to possess the core attributes of morphinan compounds, such as the potential for pain relief, sedation, and euphoria. However, it is also associated with risks like tolerance, addiction, and physical dependence. Further research is essential to comprehensively understand the specific activities, applications, and impacts of this particular morphinan compound.

4778-96-5

Post Buying Request

4778-96-5 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

4778-96-5 Usage

Uses

Used in Pharmaceutical Industry:
(5alpha,6alpha)-17-(2-phenylethyl)-4,5-epoxymorphinan-3,6,14-triol is used as a potential analgesic agent for the management of severe pain. Its classification under the morphinan class suggests that it may offer significant pain relief, similar to other opioids. However, the compound's exact efficacy and safety profile need to be thoroughly investigated to ensure its appropriate use in clinical settings.
Used in Research and Development:
(5alpha,6alpha)-17-(2-phenylethyl)-4,5-epoxymorphinan-3,6,14-triol serves as a subject of interest in scientific research, particularly in the fields of pharmacology and neuroscience. Its potential applications and impacts, as well as the mechanisms underlying its actions, are crucial areas of study. Understanding these aspects can contribute to the development of safer and more effective pain management strategies and may also provide insights into the broader opioid class of compounds.
Used in Drug Addiction and Dependence Studies:
Given the risks associated with tolerance, addiction, and physical dependence, (5alpha,6alpha)-17-(2-phenylethyl)-4,5-epoxymorphinan-3,6,14-triol is used as a research tool in addiction and dependence studies. Investigating its effects on the brain and the development of dependence can help in the design of strategies to mitigate these risks and improve the safety profile of opioid-based pain management therapies.

Check Digit Verification of cas no

The CAS Registry Mumber 4778-96-5 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 4,7,7 and 8 respectively; the second part has 2 digits, 9 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 4778-96:
(6*4)+(5*7)+(4*7)+(3*8)+(2*9)+(1*6)=135
135 % 10 = 5
So 4778-96-5 is a valid CAS Registry Number.

4778-96-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name (4R,4aS,7S,7aR,12bS)-3-(2-phenylethyl)-1,2,4,5,6,7,7a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinoline-4a,7,9-triol

1.2 Other means of identification

Product number -
Other names Normorphine,7,8-dihydro-14-hydroxy-N-phenethyl

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:4778-96-5 SDS

4778-96-5Synthetic route

4,5α-epoxy-3-methoxy-17-phenethyl-morphinane-6α,14-diol
6474-98-2

4,5α-epoxy-3-methoxy-17-phenethyl-morphinane-6α,14-diol

4,5α-epoxy-17-phenethyl-morphinane-3,6α,14-triol
4778-96-5

4,5α-epoxy-17-phenethyl-morphinane-3,6α,14-triol

Conditions
ConditionsYield
With boron tribromide In chloroform at 0 - 5℃; for 1h;63%
beta-Noroxycodol
116499-16-2

beta-Noroxycodol

4,5α-epoxy-17-phenethyl-morphinane-3,6α,14-triol
4778-96-5

4,5α-epoxy-17-phenethyl-morphinane-3,6α,14-triol

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 56 percent / NaHCO3 / dimethylformamide / 20 h / 70 °C
2: 63 percent / BBr3 / CHCl3 / 1 h / 0 - 5 °C
View Scheme
1-phenyl-2-bromoethane
103-63-9

1-phenyl-2-bromoethane

sodium salt of 4H-benz<1,4>oxazin-3-one

sodium salt of 4H-benz<1,4>oxazin-3-one

4,5α-epoxy-17-phenethyl-morphinane-3,6α,14-triol
4778-96-5

4,5α-epoxy-17-phenethyl-morphinane-3,6α,14-triol

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 56 percent / NaHCO3 / dimethylformamide / 20 h / 70 °C
2: 63 percent / BBr3 / CHCl3 / 1 h / 0 - 5 °C
View Scheme
C22H24N2O6
116388-83-1

C22H24N2O6

4,5α-epoxy-17-phenethyl-morphinane-3,6α,14-triol
4778-96-5

4,5α-epoxy-17-phenethyl-morphinane-3,6α,14-triol

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: 10percent aq. HCl / 16 h / Heating
2: 56 percent / NaHCO3 / dimethylformamide / 20 h / 70 °C
3: 63 percent / BBr3 / CHCl3 / 1 h / 0 - 5 °C
View Scheme
C24H27NO8
142641-92-7

C24H27NO8

4,5α-epoxy-17-phenethyl-morphinane-3,6α,14-triol
4778-96-5

4,5α-epoxy-17-phenethyl-morphinane-3,6α,14-triol

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: HCl gas / CH2Cl2 / 1 h
2: 56 percent / NaHCO3 / dimethylformamide / 20 h / 70 °C
3: 63 percent / BBr3 / CHCl3 / 1 h / 0 - 5 °C
View Scheme
6α,14β-diacetoxy-4,5percenta-epoxy-3-methoxy-17-methyl-morphinan
67210-64-4

6α,14β-diacetoxy-4,5percenta-epoxy-3-methoxy-17-methyl-morphinan

4,5α-epoxy-17-phenethyl-morphinane-3,6α,14-triol
4778-96-5

4,5α-epoxy-17-phenethyl-morphinane-3,6α,14-triol

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: 95 percent / CHCl3 / 16 h / Heating
2: 10percent aq. HCl / 16 h / Heating
3: 56 percent / NaHCO3 / dimethylformamide / 20 h / 70 °C
4: 63 percent / BBr3 / CHCl3 / 1 h / 0 - 5 °C
View Scheme
Multi-step reaction with 4 steps
1: 70 percent / NaHCO3 / 1,2-dichloro-ethane
2: HCl gas / CH2Cl2 / 1 h
3: 56 percent / NaHCO3 / dimethylformamide / 20 h / 70 °C
4: 63 percent / BBr3 / CHCl3 / 1 h / 0 - 5 °C
View Scheme

4778-96-5Downstream Products

4778-96-5Relevant academic research and scientific papers

Morphine Alkaloids, Part 114 A. Stereohomogeneous Synthesis of N-Demethyl-N-Substituted-14-Hydroxydihydromorphines

Hosztafi, Sandor,Berenyi, Sandor,Toth, Geza,Makleit, Sandor

, p. 435 - 442 (2007/10/02)

A new route for the stereohomogeneous synthesis of N-demethyl-N-substituted-14-hydroxydihydromorphines 2a-f has been elaborated, involving O-demethylation of the novel dihydrocodeine derivatives 6a-f, obtained upon alkylation of the hitherto unknown N-demethyl-14-hydroxydihydrocodeine (5). Keywords. 6α,14β-Diacetoxy-4,5α-epoxy-3-methoxy-17-methyl-morphinan, N-demethylation of; 3,6α,14β-Triacetoxy-17-alkyl-4,5α-epoxymorphinan, N-demethylation of; 17-Alkyl-4,5α-epoxy-6α,14β-dihydroxy-3-methoxymorphinan, O-demethylation of; 4,5α-Epoxy-6α,14β-dihydroxy-3-methoxymorphinan, N-alkylation of.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 4778-96-5